Company registration number SC474600 (Scotland)
LINDEN NEUROLOGICAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023
PAGES FOR FILING WITH REGISTRAR
LINDEN NEUROLOGICAL SERVICES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
LINDEN NEUROLOGICAL SERVICES LIMITED
BALANCE SHEET
AS AT
30 APRIL 2023
30 April 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
4,260
2,717
Investments
4
57,100
54,600
61,360
57,317
Current assets
Debtors
5
7,705
2,121
Cash at bank and in hand
71,456
86,413
79,161
88,534
Creditors: amounts falling due within one year
6
(3,905)
(3,319)
Net current assets
75,256
85,215
Total assets less current liabilities
136,616
142,532
Provisions for liabilities
(294)
(516)
Net assets
136,322
142,016
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
136,222
141,916
Total equity
136,322
142,016

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

LINDEN NEUROLOGICAL SERVICES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2023
30 April 2023
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 11 January 2024 and are signed on its behalf by:
Dr J I O'Riordan
Director
Company registration number SC474600 (Scotland)
LINDEN NEUROLOGICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023
- 3 -
1
Accounting policies
Company information

Linden Neurological Services Limited is a private company limited by shares incorporated in Scotland. The registered office is Chapelshade House, 78-84 Bell Street, Dundee, Scotland, DD1 1HN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on reducing balance
Fixtures and fittings
25% on reducing balance
Computers
33% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

LINDEN NEUROLOGICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
1
1
3
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 May 2022
433
2,155
5,022
7,610
Additions
245
-
0
3,317
3,562
Disposals
-
0
-
0
(120)
(120)
At 30 April 2023
678
2,155
8,219
11,052
Depreciation and impairment
At 1 May 2022
323
1,840
2,730
4,893
Depreciation charged in the year
87
77
1,844
2,008
Eliminated in respect of disposals
-
0
-
0
(109)
(109)
At 30 April 2023
410
1,917
4,465
6,792
Carrying amount
At 30 April 2023
268
238
3,754
4,260
At 30 April 2022
110
315
2,292
2,717
LINDEN NEUROLOGICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
- 5 -
4
Fixed asset investments
2023
2022
£
£
Other investments other than loans
57,100
54,600
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 May 2022
54,600
Additions
2,500
At 30 April 2023
57,100
Carrying amount
At 30 April 2023
57,100
At 30 April 2022
54,600
5
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
7,705
2,121
6
Creditors: amounts falling due within one year
2023
2022
£
£
Corporation tax
2,093
1,808
Other creditors
1,812
1,511
3,905
3,319
7
Directors' transactions
Description
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
Director's Loan
-
(2,121)
(5,584)
(7,705)
(2,121)
(5,584)
(7,705)
2023-04-302022-05-01false11 January 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityDr J I O'RiordanDr E O'RiordanfalseSC4746002022-05-012023-04-30SC4746002023-04-30SC4746002022-04-30SC474600core:PlantMachinery2023-04-30SC474600core:FurnitureFittings2023-04-30SC474600core:ComputerEquipment2023-04-30SC474600core:PlantMachinery2022-04-30SC474600core:FurnitureFittings2022-04-30SC474600core:ComputerEquipment2022-04-30SC474600core:CurrentFinancialInstrumentscore:WithinOneYear2023-04-30SC474600core:CurrentFinancialInstrumentscore:WithinOneYear2022-04-30SC474600core:CurrentFinancialInstruments2023-04-30SC474600core:CurrentFinancialInstruments2022-04-30SC474600core:ShareCapital2023-04-30SC474600core:ShareCapital2022-04-30SC474600core:RetainedEarningsAccumulatedLosses2023-04-30SC474600core:RetainedEarningsAccumulatedLosses2022-04-30SC474600bus:Director12022-05-012023-04-30SC474600core:PlantMachinery2022-05-012023-04-30SC474600core:FurnitureFittings2022-05-012023-04-30SC474600core:ComputerEquipment2022-05-012023-04-30SC4746002021-05-012022-04-30SC474600core:PlantMachinery2022-04-30SC474600core:FurnitureFittings2022-04-30SC474600core:ComputerEquipment2022-04-30SC4746002022-04-30SC474600core:WithinOneYear2023-04-30SC474600core:WithinOneYear2022-04-30SC474600bus:PrivateLimitedCompanyLtd2022-05-012023-04-30SC474600bus:SmallCompaniesRegimeForAccounts2022-05-012023-04-30SC474600bus:FRS1022022-05-012023-04-30SC474600bus:AuditExemptWithAccountantsReport2022-05-012023-04-30SC474600bus:Director22022-05-012023-04-30SC474600bus:FullAccounts2022-05-012023-04-30xbrli:purexbrli:sharesiso4217:GBP